Excerpt: "Physicians from UCLA, together with collaborators, have reported
tantalizingly positive anecdotal results from the compassionate use of the humanized monoclonal antibody lerorimab made by CytoDyn in the treatment of COVID-19 in 23 severely/critically ill patients. The results were reported online on October 20, 2020 in Clinical Infectious Diseases
https://academic.oup.com/cid/advance-article/...a1583/59...